2-162318050-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022168.4(IFIH1):​c.258C>G​(p.Thr86Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000825 in 1,614,146 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T86T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0044 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 3 hom. )

Consequence

IFIH1
NM_022168.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.99

Publications

1 publications found
Variant links:
Genes affected
IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]
IFIH1 Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Illumina, G2P, Labcorp Genetics (formerly Invitae)
  • IFIH1-related type 1 interferonopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Singleton-Merten syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Singleton-Merten dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 95
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-162318050-G-C is Benign according to our data. Variant chr2-162318050-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 474953.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00445 (677/152270) while in subpopulation AFR AF = 0.0158 (656/41564). AF 95% confidence interval is 0.0148. There are 5 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022168.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
NM_022168.4
MANE Select
c.258C>Gp.Thr86Thr
synonymous
Exon 1 of 16NP_071451.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
ENST00000649979.2
MANE Select
c.258C>Gp.Thr86Thr
synonymous
Exon 1 of 16ENSP00000497271.1
IFIH1
ENST00000421365.2
TSL:1
c.258C>Gp.Thr86Thr
synonymous
Exon 1 of 2ENSP00000408450.2
IFIH1
ENST00000648433.1
c.258C>Gp.Thr86Thr
synonymous
Exon 1 of 15ENSP00000496816.1

Frequencies

GnomAD3 genomes
AF:
0.00446
AC:
678
AN:
152152
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00119
AC:
300
AN:
251442
AF XY:
0.000861
show subpopulations
Gnomad AFR exome
AF:
0.0172
Gnomad AMR exome
AF:
0.000520
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000447
AC:
654
AN:
1461876
Hom.:
3
Cov.:
31
AF XY:
0.000375
AC XY:
273
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0164
AC:
549
AN:
33480
American (AMR)
AF:
0.000626
AC:
28
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000719
AC:
8
AN:
1112008
Other (OTH)
AF:
0.00103
AC:
62
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
43
87
130
174
217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00445
AC:
677
AN:
152270
Hom.:
5
Cov.:
32
AF XY:
0.00427
AC XY:
318
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0158
AC:
656
AN:
41564
American (AMR)
AF:
0.000850
AC:
13
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68018
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
36
72
108
144
180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000492
Hom.:
0
Bravo
AF:
0.00499
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1 (1)
-
-
1
IFIH1-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.019
DANN
Benign
0.68
PhyloP100
-5.0
PromoterAI
-0.0050
Neutral
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143870870; hg19: chr2-163174560; API